Lyell Immunopharma Stock (NASDAQ: LYEL) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 919.141K |
Day Range | - - - |
52 Wk Range | 1.320 - 3.970 |
Market Cap | $586.355M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 49 |
Short Interest | 10.1% |
Days to Cover | 21.49 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Lyell Immunopharma (NASDAQ: LYEL) through any online brokerage.
Other companies in Lyell Immunopharma’s space includes: Cabaletta Bio (NASDAQ:CABA), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC), Cogent Biosciences (NASDAQ:COGT) and Korro Bio (NASDAQ:KRRO).
The latest price target for Lyell Immunopharma (NASDAQ: LYEL) was reported by HC Wainwright & Co. on Thursday, February 29, 2024. The analyst firm set a price target for 6.00 expecting LYEL to rise to within 12 months (a possible 160.87% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Lyell Immunopharma (NASDAQ: LYEL) is $2.3 last updated April 24, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Lyell Immunopharma.
Lyell Immunopharma’s Q1 earnings are confirmed for Monday, May 6, 2024.
There is no upcoming split for Lyell Immunopharma.
Lyell Immunopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.